[go: up one dir, main page]

DK1954264T3 - Fremgangsmåde til fremstilling af epoxybutanol-mellemprodukter - Google Patents

Fremgangsmåde til fremstilling af epoxybutanol-mellemprodukter

Info

Publication number
DK1954264T3
DK1954264T3 DK06804890T DK06804890T DK1954264T3 DK 1954264 T3 DK1954264 T3 DK 1954264T3 DK 06804890 T DK06804890 T DK 06804890T DK 06804890 T DK06804890 T DK 06804890T DK 1954264 T3 DK1954264 T3 DK 1954264T3
Authority
DK
Denmark
Prior art keywords
formula
intermediates
preparation
ethyl
prg
Prior art date
Application number
DK06804890T
Other languages
English (en)
Inventor
Marc Muller
Lin Xu
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Application granted granted Critical
Publication of DK1954264T3 publication Critical patent/DK1954264T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/08Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
DK06804890T 2005-12-01 2006-11-29 Fremgangsmåde til fremstilling af epoxybutanol-mellemprodukter DK1954264T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05026163 2005-12-01
PCT/CH2006/000671 WO2007062542A2 (en) 2005-12-01 2006-11-29 Process for the manufacture of epoxybutanol intermediates

Publications (1)

Publication Number Publication Date
DK1954264T3 true DK1954264T3 (da) 2010-01-11

Family

ID=36178579

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06804890T DK1954264T3 (da) 2005-12-01 2006-11-29 Fremgangsmåde til fremstilling af epoxybutanol-mellemprodukter

Country Status (19)

Country Link
US (2) US7816537B2 (da)
EP (2) EP2133345A1 (da)
JP (1) JP5329969B2 (da)
KR (1) KR101191682B1 (da)
CN (1) CN101321522B (da)
AT (1) ATE444747T1 (da)
AU (2) AU2006319657B2 (da)
BR (1) BRPI0619120B1 (da)
CA (2) CA2629092C (da)
CY (1) CY1110588T1 (da)
DE (1) DE602006009698D1 (da)
DK (1) DK1954264T3 (da)
ES (1) ES2333258T3 (da)
HR (1) HRP20090675T1 (da)
PL (1) PL1954264T3 (da)
PT (1) PT1954264E (da)
SI (1) SI1954264T1 (da)
WO (1) WO2007062542A2 (da)
ZA (1) ZA200804218B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102596979B (zh) 2009-09-21 2014-12-10 吉里德科学公司 用于制备1’-取代碳核苷类似物的方法和中间体
MX2013000744A (es) 2010-07-22 2013-03-07 Gilead Sciences Inc Metodos y compuestos para tratar infecciones virales por paramyxoviridae.
SI2882723T1 (sl) 2012-08-07 2017-04-26 Basilea Pharmaceutica Ag Postopek izdelave izavukonazola ali ravukonazola
WO2015150947A1 (en) 2014-03-29 2015-10-08 Wockhardt Limited A process for the preparation of isavuconazole and its intermediates
TWI687432B (zh) 2014-10-29 2020-03-11 美商基利科學股份有限公司 絲狀病毒科病毒感染之治療
SG10202001878WA (en) 2015-09-16 2020-04-29 Gilead Sciences Inc Methods for treating arenaviridae and coronaviridae virus infections
CN105367528A (zh) * 2015-11-10 2016-03-02 南通诺泰生物医药技术有限公司 一种三唑类药物中间体(d)-1-(1-环烷仲胺基)-2-(2-四氢吡喃基)氧-1-丙酮类化合物及合成方法
US10682368B2 (en) 2017-03-14 2020-06-16 Gilead Sciences, Inc. Methods of treating feline coronavirus infections
JP2020518578A (ja) 2017-05-01 2020-06-25 ギリアード サイエンシーズ, インコーポレイテッド (S)−2−エチルブチル2−(((S)−(((2R,3S,4R,5R)−5−(4−アミノピロロ[2,1−f][1,2,4]トリアジン−7−イル)−5−シアノ−3,4−ジヒドロキシテトラヒドロフラン−2−イル)メトキシ)(フェノキシ)ホスホリル)アミノ)プロパノエートの結晶形態
US10675296B2 (en) 2017-07-11 2020-06-09 Gilead Sciences, Inc. Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
JP7060019B2 (ja) 2017-08-10 2022-04-26 住友化学株式会社 エポキシアルコール化合物の製造方法
JP2023512656A (ja) 2020-01-27 2023-03-28 ギリアード サイエンシーズ, インコーポレイテッド SARS CoV-2感染を治療するための方法
JP7554841B2 (ja) 2020-03-12 2024-09-20 ギリアード サイエンシーズ, インコーポレイテッド 1’-シアノヌクレオシドを調製する方法
US11701372B2 (en) 2020-04-06 2023-07-18 Gilead Sciences, Inc. Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs
WO2021243157A1 (en) 2020-05-29 2021-12-02 Gilead Sciences, Inc. Remdesivir treatment methods
EP4172160A2 (en) 2020-06-24 2023-05-03 Gilead Sciences, Inc. 1'-cyano nucleoside analogs and uses thereof
HRP20240733T1 (hr) 2020-08-27 2024-08-30 Gilead Sciences, Inc. Spojevi i postupci za liječenje virusnih infekcija
JP7605002B2 (ja) 2021-04-01 2024-12-24 東洋紡株式会社 表面処理プラスチックフィルム
WO2023167944A1 (en) 2022-03-02 2023-09-07 Gilead Sciences, Inc. Compounds and methods for treatment of viral infections
CN115536643A (zh) * 2022-12-05 2022-12-30 南京桦冠生物技术有限公司 一种艾沙康唑类药物关键中间体的制备方法
CN119264078A (zh) * 2024-12-09 2025-01-07 浙江世佳科技股份有限公司 一种(5s,6r)-5,6-环氧-2-十七碳炔-1-醇的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3452213B2 (ja) * 1994-07-05 2003-09-29 エーザイ株式会社 抗真菌剤及びその製造方法
WO1999045008A1 (en) * 1998-03-06 1999-09-10 F. Hoffmann-La Roche Ag 3-[4-(4-cyanophenyl)thiazol-2-y)]-1-(1h-1,2,4-triazol-1-yl)-butan-2-ol derivatives having antifungal activity
US6133485A (en) * 1998-04-15 2000-10-17 Synphar Laboratories, Inc. Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
US6391903B1 (en) * 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
US6884892B2 (en) * 2002-06-20 2005-04-26 Sumitomo Chemical Company, Limited Production methods of epoxytriazole derivative and intermediate therefor
JP4627413B2 (ja) * 2003-05-06 2011-02-09 三井化学株式会社 1−アゾール−2−フェニル−2、3−プロパンジオール誘導体の製造法

Also Published As

Publication number Publication date
CN101321522A (zh) 2008-12-10
WO2007062542A2 (en) 2007-06-07
ES2333258T3 (es) 2010-02-18
EP1954264A2 (en) 2008-08-13
CY1110588T1 (el) 2015-04-29
US20090299073A1 (en) 2009-12-03
ZA200804218B (en) 2009-01-28
CA2711852A1 (en) 2007-06-07
AU2006319657A1 (en) 2007-06-07
DE602006009698D1 (de) 2009-11-19
PL1954264T3 (pl) 2010-02-26
BRPI0619120A2 (pt) 2011-09-13
HRP20090675T1 (hr) 2010-01-31
US8076494B2 (en) 2011-12-13
AU2010203301B2 (en) 2012-06-21
CN101321522B (zh) 2012-05-30
AU2010203301A1 (en) 2010-08-12
US7816537B2 (en) 2010-10-19
AU2006319657B2 (en) 2010-08-12
SI1954264T1 (sl) 2010-01-29
CA2629092A1 (en) 2007-06-07
PT1954264E (pt) 2009-12-23
KR20080075014A (ko) 2008-08-13
EP2133345A1 (en) 2009-12-16
ATE444747T1 (de) 2009-10-15
BRPI0619120B1 (pt) 2023-10-10
JP5329969B2 (ja) 2013-10-30
US20110021794A1 (en) 2011-01-27
EP1954264B1 (en) 2009-10-07
CA2629092C (en) 2012-01-03
KR101191682B1 (ko) 2012-10-16
WO2007062542A3 (en) 2007-11-01
CA2711852C (en) 2011-10-04
JP2009517413A (ja) 2009-04-30

Similar Documents

Publication Publication Date Title
DK1954264T3 (da) Fremgangsmåde til fremstilling af epoxybutanol-mellemprodukter
ECSP099091A (es) Profarmaco de compuesto de cinamida
NO20062644L (no) DPP-IV inhibitorer
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
AR057914A1 (es) Compuestos organicos de azufre y su uso
DK1781683T3 (da) Fremgangsmåde til fremstilling af 17-vinyl-triflater som halvfabrikata
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
DK1673370T3 (da) Krystallingsk form af linezolid
DK1817301T3 (da) Forstærkere af glutamat-receptorer
DK1951747T3 (da) Fremgangsmåde og mellemprodukter til syntese af caspofungin
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
HK1164114A1 (en) Antidepressant containing heterocyclic compound having specific structure
IL208290A0 (en) Process for the preparation of 10-deacetyl-bis-7, 10- trichloroacetylbaccatin iii
ATE503746T1 (de) Neue imidazolidinderivate
DK1601653T3 (da) Fremgangsmåde til fremstilling af substituerede nikotinsyreestre
DK1902036T3 (da) Fremgangsmåde til fremstilling af rosuvastatin og intermediære
GB0501964D0 (en) Chemical compounds
MY148980A (en) Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
DE502006005865D1 (de) Herstellung von 1,7` -dimethyl-2` -propyl-2,5` -bi-1h-benzimidazol
IL183805A0 (en) Process for preparing substituted thiophenesulfonyl isocyanates
DE602006008836D1 (de) Reaktionsprodukt von Resorcin und Methylethylketon
DK1558560T3 (da) Fremgangsmåde til fremstilling af 2,6-dihalogen-para-trifluormenthylanilin
NO20053261D0 (no) Fremgangsmate for a fremstille 1-acetoksy-3- (substituert fenyl) propen-forbindelse.
SE0402734D0 (sv) Antimiicrobial compounds